Z Squared Inc (Delaware)
ZSQR
NASDAQ
Biotechnology
$3.94
USD
-0.22 (-5.29%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $219.83M
Volume 248.9K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
MYGN | Myriad Genetics Inc | $307.03M | - | -3.2% | - | |
AVXL | Anavex Life Sciences Corp | $300.34M | - | - | - | |
TRDA | Entrada Therapeutics Inc | $290.08M | - | -94.1% | - | |
ANIK | Anika Therapeutics Inc | $286.13M | - | -2.5% | - | |
ELDN | Eledon Pharmaceuticals Inc | $285.59M | - | - | - | |
SRZN | Surrozen Inc | $278.91M | - | -35.6% | - | |
ALXO | ALX Oncology Holdings Inc | $272.41M | - | - | - | |
RNAC | Cartesian Therapeutics Inc | $267.91M | - | -94.9% | - | |
ZSQR | Z Squared Inc (Delaware) | $219.83M | - | +2149.0% | - |
Top Peer by Growth
Z Squared Inc (Delaware)
+2149.0% YoY Revenue
Best 1-Year Return
ALX Oncology Holdings Inc
+226.8% Return